Device
Optilume® BPH Catheter System
Optilume® BPH Catheter System is a medical device with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting267%
active_not_recruiting133%
Recent Activity
3 active trials
Showing 3 of 3
recruitingnot_applicable
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
NCT06312722
recruitingnot_applicable
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia
NCT06769997
active_not_recruitingnot_applicable
Optilume™ BPH Catheter System in Men With Symptomatic BPH
NCT04131907
Clinical Trials (3)
Showing 3 of 3 trials
NCT06312722Not Applicable
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
NCT06769997Not Applicable
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia
NCT04131907Not Applicable
Optilume™ BPH Catheter System in Men With Symptomatic BPH
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3